Skip to main content
. 2022 Dec 8;13:1056944. doi: 10.3389/fimmu.2022.1056944

Table 3.

Univariate and multivariate Cox proportional hazard regression analysis for disability.

Baseline Variables EDSS≥6 EDSS≥8
Univariate Multivariate Univariate Multivariate
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Onset age 1.59 (1.31 - 1.94) <0.001 1.47 (1.20- 1.88) <0.001 2.05 (1.46 - 2.89) <0.001 1.74 (1.25 - 2.47) 0.002
Female 1.02 (0.52 - 1.99) 0.964 / / 0.73 (0.28 - 1.94) 0.526 / /
TM as first attack 1.58 (0.97 - 2.57) 0.068 1.04 (0.54 - 1.93) 0.906 1.39 (0.64 - 3.02) 0.403 / /
ON as first attack 0.45 (0.24 - 0.82) 0.009 0.50 (0.19 - 0.94) 0.035 0.35 (0.12- 1.02) 0.055 0.38 (0.12 - 1.18) 0.093
Brainstem/Cerebral as first attack 1.14 (0.54 - 2.40) 0.725 / / 0.55 (0.23 - 1.31) 0.179 / /
Abnormal CSF 2.24 (1.35 - 3.70) 0.002 2.26 (1.34 - 3.83) 0.002 3.20 (1.43 - 7.18) 0.005 2.95 (1.29 - 6.74) 0.010
AQP4-IgG positive 1.03 (0.53 - 2.04) 0.923 / / 1.32 (0.49 - 3.54) 0.581 / /
PE/IVIG during acute phase 1.58 (0.98 - 2.56) 0.063 1.43 (0.86 - 2.40) 0.172 0.68 (0.32 - 1.47) 0.330 / /
Maintenance treatment of IST 0.52 (0.28 - 0.93) 0.028 0.72 (0.37 - 1.36) 0.302 0.26 (0.11 - 0.61) 0.002 0.43 (0.17 - 1.05) 0.063

EDSS, Expanded Disability Status Scale; HR, hazard ratio; CI, confidence interval; TM, transverse myelitis; ON, optic neuritis; CSF, cerebrospinal fluid; AQP4-IgG, aquaporin-4 immunoglobin G; PE, plasma exchange; IVIG, intravenous immunogloblin; IST, immunosuppressive therapy.

p values <0.05 were bolded.